3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Unknown
5
Recruiting
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
33
Pancreatic Neoplasms
14
Neuroblastoma
12
Neoplasm Metastasis
10
Stomach Neoplasms
8
Neoplasms
8
Rectal Neoplasms
5
Small Cell Lung Carcinoma
4
Esophageal Squamous Cell Carcinoma
4
Colonic Neoplasms
4
Sarcoma, Ewing
3
Rhabdomyosarcoma
3
Ovarian Neoplasms
3
Breast Neoplasms
3
Adenocarcinoma
3
Wilms Tumor
2
Sarcoma
2
Recurrence
2
Osteosarcoma
2
Gastrointestinal Neoplasms
2
Ganglioneuroblastoma
2
Esophageal Neoplasms
2
Endometrial Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Biliary Tract Neoplasms
2
Adenocarcinoma Of Esophagus
2
Uterine Neoplasms
1
Triple Negative Breast Neoplasms
1
Stage I Mixed Cell Type Kidney Wilms Tumor
1
Solid Tumors
1
Interventions
Capecitabine
7
Oxaliplatin
6
toripalimab
2
camrelizumab
2
Immune Checkpoint Inhibitors
2
Fluorouracil
2
spartalizumab
1
irinotecan sucrosofate
1
Radiotherapy, Intensity-Modulated
1
Leucovorin
1
Irinotecan
1
Celecoxib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Locally Advanced Rectal Cancer
×
Irinotecan
×
Clear all
NCT05412082
2026-02-06
SMART TNT
University of Miami
Phase 1
Recruiting
25 enrolled